CD68 and neoplasm: In this study, by using multivariate Cox analysis, two commonly used clinical indicators (tumor size and MVI) were identified as independent predictors for survival and then were incorporated into the HBx-CD68-based prognostic model, thus providing more accuracy in the prediction of clinical outcomes for patients with HBV-related HCC.